Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 6 | 2019 | 140 | 1.210 |
Why?
|
| Motivational Interviewing | 7 | 2021 | 52 | 1.040 |
Why?
|
| Suicide | 2 | 2020 | 7 | 0.980 |
Why?
|
| Adult | 18 | 2021 | 1233 | 0.870 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 7 | 0.810 |
Why?
|
| Papillomavirus Vaccines | 1 | 2021 | 8 | 0.800 |
Why?
|
| Smoking Cessation | 5 | 2021 | 75 | 0.730 |
Why?
|
| Male | 20 | 2022 | 3197 | 0.720 |
Why?
|
| Female | 20 | 2022 | 3436 | 0.700 |
Why?
|
| Humans | 26 | 2024 | 6599 | 0.620 |
Why?
|
| Middle Aged | 14 | 2020 | 648 | 0.610 |
Why?
|
| Religion and Sex | 1 | 2017 | 1 | 0.610 |
Why?
|
| Criminals | 1 | 2017 | 1 | 0.610 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 80 | 0.580 |
Why?
|
| Risk Assessment | 1 | 2017 | 130 | 0.580 |
Why?
|
| Parents | 4 | 2024 | 149 | 0.580 |
Why?
|
| Health Behavior | 4 | 2021 | 72 | 0.560 |
Why?
|
| Mass Screening | 5 | 2020 | 41 | 0.540 |
Why?
|
| Communication | 4 | 2022 | 54 | 0.520 |
Why?
|
| Surveys and Questionnaires | 7 | 2020 | 290 | 0.510 |
Why?
|
| Health Promotion | 3 | 2020 | 50 | 0.500 |
Why?
|
| Young Adult | 9 | 2020 | 652 | 0.470 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 238 | 0.470 |
Why?
|
| Anti-HIV Agents | 2 | 2012 | 36 | 0.430 |
Why?
|
| Respiratory Tract Infections | 3 | 2022 | 75 | 0.390 |
Why?
|
| Outpatients | 2 | 2020 | 28 | 0.390 |
Why?
|
| Patient Compliance | 4 | 2017 | 70 | 0.360 |
Why?
|
| Directly Observed Therapy | 1 | 2008 | 5 | 0.330 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2008 | 12 | 0.330 |
Why?
|
| Adolescent | 8 | 2024 | 2087 | 0.330 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 64 | 0.310 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2018 | 8 | 0.310 |
Why?
|
| Health Education | 4 | 2021 | 39 | 0.290 |
Why?
|
| Child | 5 | 2024 | 3146 | 0.290 |
Why?
|
| Smoking | 4 | 2021 | 69 | 0.290 |
Why?
|
| Religion | 2 | 2019 | 10 | 0.270 |
Why?
|
| Motivation | 4 | 2021 | 64 | 0.240 |
Why?
|
| Mental Health | 1 | 2024 | 18 | 0.240 |
Why?
|
| Rare Diseases | 1 | 2024 | 37 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2021 | 124 | 0.230 |
Why?
|
| Protestantism | 2 | 2020 | 6 | 0.230 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 21 | 0.220 |
Why?
|
| Inappropriate Prescribing | 2 | 2022 | 27 | 0.220 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 49 | 0.220 |
Why?
|
| Community-Institutional Relations | 2 | 2019 | 9 | 0.210 |
Why?
|
| Risk Reduction Behavior | 2 | 2020 | 14 | 0.210 |
Why?
|
| Feedback | 1 | 2021 | 7 | 0.200 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 7 | 0.200 |
Why?
|
| Vaccination | 1 | 2021 | 68 | 0.200 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 36 | 0.190 |
Why?
|
| Video Recording | 1 | 2020 | 14 | 0.190 |
Why?
|
| Medication Adherence | 2 | 2018 | 59 | 0.180 |
Why?
|
| Counseling | 3 | 2017 | 60 | 0.180 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 18 | 0.170 |
Why?
|
| Patient Selection | 2 | 2016 | 40 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 41 | 0.170 |
Why?
|
| Psychometrics | 1 | 2018 | 33 | 0.170 |
Why?
|
| Decision Making | 1 | 2018 | 34 | 0.170 |
Why?
|
| Health Communication | 1 | 2018 | 6 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 44 | 0.160 |
Why?
|
| Ambulatory Care Facilities | 1 | 2018 | 38 | 0.160 |
Why?
|
| Religion and Medicine | 1 | 2017 | 4 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 18 | 0.160 |
Why?
|
| Infant | 5 | 2022 | 1396 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2022 | 1459 | 0.160 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 37 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 82 | 0.150 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2017 | 9 | 0.150 |
Why?
|
| Genetic Research | 1 | 2016 | 6 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2016 | 4 | 0.140 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 9 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2016 | 20 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2016 | 19 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2020 | 624 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 30 | 0.140 |
Why?
|
| Treatment Refusal | 1 | 2015 | 6 | 0.140 |
Why?
|
| Antirheumatic Agents | 1 | 2015 | 14 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2016 | 50 | 0.140 |
Why?
|
| Community-Based Participatory Research | 2 | 2017 | 10 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 81 | 0.130 |
Why?
|
| Telemedicine | 1 | 2016 | 64 | 0.130 |
Why?
|
| Aged | 3 | 2020 | 375 | 0.110 |
Why?
|
| Feasibility Studies | 2 | 2020 | 66 | 0.090 |
Why?
|
| Cultural Characteristics | 1 | 2009 | 3 | 0.090 |
Why?
|
| Primary Health Care | 2 | 2020 | 44 | 0.090 |
Why?
|
| Community Health Services | 1 | 2009 | 9 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 150 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2008 | 41 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 317 | 0.080 |
Why?
|
| Patient Satisfaction | 2 | 2018 | 41 | 0.080 |
Why?
|
| Health Status Disparities | 2 | 2017 | 22 | 0.080 |
Why?
|
| Telephone | 2 | 2017 | 12 | 0.070 |
Why?
|
| Urban Population | 2 | 2016 | 36 | 0.070 |
Why?
|
| Time Factors | 2 | 2016 | 241 | 0.070 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 24 | 0.060 |
Why?
|
| United States | 2 | 2020 | 646 | 0.060 |
Why?
|
| Missouri | 2 | 2017 | 78 | 0.060 |
Why?
|
| Prescriptions | 1 | 2022 | 10 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2020 | 46 | 0.050 |
Why?
|
| Kansas | 2 | 2010 | 49 | 0.040 |
Why?
|
| Religious Personnel | 1 | 2019 | 3 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2019 | 6 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 16 | 0.040 |
Why?
|
| Translations | 1 | 2018 | 5 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2019 | 35 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 26 | 0.040 |
Why?
|
| Patient Participation | 1 | 2018 | 21 | 0.040 |
Why?
|
| Health Priorities | 1 | 2017 | 3 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2018 | 35 | 0.040 |
Why?
|
| Research Design | 1 | 2018 | 64 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 197 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 62 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2017 | 21 | 0.040 |
Why?
|
| Health Status | 1 | 2017 | 28 | 0.040 |
Why?
|
| Program Development | 1 | 2017 | 16 | 0.040 |
Why?
|
| Stroke | 1 | 2017 | 24 | 0.040 |
Why?
|
| Disease Progression | 1 | 2017 | 104 | 0.040 |
Why?
|
| Research Subjects | 1 | 2016 | 3 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2016 | 39 | 0.040 |
Why?
|
| Remote Sensing Technology | 1 | 2016 | 4 | 0.040 |
Why?
|
| Cloud Computing | 1 | 2016 | 5 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 7 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2016 | 8 | 0.040 |
Why?
|
| Attitude to Computers | 1 | 2016 | 5 | 0.040 |
Why?
|
| Computers, Handheld | 1 | 2016 | 11 | 0.040 |
Why?
|
| Pediatrics | 1 | 2018 | 170 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 99 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 52 | 0.030 |
Why?
|
| Caregivers | 1 | 2016 | 38 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 33 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 51 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 315 | 0.030 |
Why?
|
| Varenicline | 1 | 2012 | 4 | 0.030 |
Why?
|
| Quinoxalines | 1 | 2012 | 4 | 0.030 |
Why?
|
| Benzazepines | 1 | 2012 | 6 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 2012 | 9 | 0.030 |
Why?
|
| Audiovisual Aids | 1 | 2012 | 4 | 0.030 |
Why?
|
| Electronics, Medical | 1 | 2012 | 5 | 0.030 |
Why?
|
| Health Resources | 1 | 2012 | 17 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2012 | 19 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 63 | 0.030 |
Why?
|
| Focus Groups | 1 | 2010 | 13 | 0.020 |
Why?
|
| Consumer Health Information | 1 | 2009 | 2 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 8 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2009 | 18 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 20 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2009 | 28 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 38 | 0.020 |
Why?
|